A new study found that genetics contribute to individual differences in empathy, with genetic variants associated with lower empathy linked to higher autism risk. Women are also more empathetic than men, but this difference is not due to DNA, suggesting non-genetic factors at play.
A study found that reducing co-payments for patients with heart attack medication improved both patient and physician adherence to recommended treatment. The study also found no significant differences in rates of death, heart attack, or stroke between groups.
A study found that women with breast cancer who took the beta blocker carvedilol during chemotherapy had lower levels of a protein indicative of heart injury, but no difference in heart function. The study's lead author notes that further research is needed to confirm these findings and explore potential benefits for higher-risk patients.
A study found that ACE-inhibitors and beta blockers can reduce the risk of heart damage in women receiving anthracycline-based chemotherapy alongside trastuzumab. However, these medications were not effective for those without a history of anthracycline exposure.
A new study published in Translational Psychiatry found that genetic variations contribute to individual differences in empathy, with women generally showing higher levels of empathy than men. The research also linked genetic variants associated with lower empathy to a higher risk for autism.
A new inhaled medication for heart failure with preserved ejection fraction failed to improve exercise capacity, daily activity levels, or quality of life. The study's findings suggest that adherence issues and short treatment duration may have contributed to the treatment's ineffectiveness.
A new study found that patients who underwent transcatheter aortic valve replacement experienced significant improvements in their quality of life, ranking their healthiest possible score at 72.9/100 just 30 days post-procedure. This improvement was sustained up to one year after the procedure.
A study found that over half of stroke patients require assistance with taking medicine, with younger survivors and those dependent on others facing greater barriers. The research highlights the need for new interventions to improve adherence to treatment among stroke survivors.
A team of researchers has successfully developed an imaging technique that can monitor the movement of atomic units at a high resolution of 300 nanometers. The technology is expected to be used in the development of new materials, solar cells, and catalysts.
A multi-arm, placebo-controlled study showed that ACE inhibitors and beta blockers can significantly offset the risk of heart problems for patients with HER2-positive breast cancer. The data demonstrated a significant reduction in cardiotoxicity for patients on these medications who received doxorubicin before Herceptin.
A recent study published in Biological Conservation shows that eBird citizen science data accurately tracks trends in government bird surveys, filling data gaps in developing nations. The analysis, led by University of Utah researcher Joshua Horns, reveals significant declines for 48% of North American bird species over the past 20 years.
A new study by the Intermountain Medical Center Heart Institute has identified protein pathways associated with changes in triglyceride and hemoglobin A1c levels in diabetic patients. The findings suggest a link between these pathways and increased risk of cardiovascular events, such as heart attack, stroke, or death.
Researchers found that offsetting medication costs with vouchers increased the use of effective anti-platelet drugs among heart attack survivors. Despite improved adherence, clinical outcomes such as death and stroke rates remained unchanged.
Researchers have discovered that muscle wasting in old age follows changes in the nervous system, which can be reversed with healthy muscles. The study found that surviving nerves can send out new branches to rescue detached muscle fibers, but this process is not successful in everyone.
Patients treated with dabigatran had a 28% lower risk of major cardiovascular complications compared to those receiving a placebo. Dabigatran also showed significant benefits in reducing the risk of specific events such as heart attack, stroke and blood clots.
Patients with advanced heart failure who received a novel heart pump experienced no malfunctions requiring replacement, and their risk of stroke was halved compared to those who received the established version. The new device uses fully magnetic levitation technology to push blood through the device and into the aorta.
A new study found that using genetic information to inform drug choice reduced adverse events by 42 percent in patients with acute coronary syndrome. Genetic testing led to different prescribing patterns, including more frequent use of prasugrel and ticagrelor.
The MOMENTUM 3 clinical trial found that advanced heart-failure patients who received a centrifugal-flow circulatory pump had significantly lower rates of pump-related blood clots and stroke compared to those receiving an axial flow pump. Patients who received the centrifugal-flow pump also had fewer re-operations due to device malfunc...
In a trial of over 3,800 patients treated for STEMI at more than 180 centers, researchers found that ticagrelor is safe to use in combination with clot busters in patients younger than 75. The study met its primary endpoint indicating no difference in major bleeding rates between ticagrelor and clopidogrel.
A large trial found that statins significantly reduced major adverse cardiac events among patients undergoing PCI, but not in the broader population. Patients who received a loading dose of statin before PCI were 28% less likely to experience a major adverse cardiac event and 32% less likely to have a heart attack.